Kepler Capital analyst David Evans maintained a Buy rating on Novartis AG (NOVN – Research Report) on April 24 and set a price target of ...

In what could be seen as a bellwether for the pharmaceutical industry's sweeping shift toward localised manufacturing—spurred ...

Filing of intimation u/r 39(3) for loss of share certificates received from the Companys'' RTA dated September 12, 2024.

The European Union should allow drug prices to rise to U.S. levels in order to attract investment, the bosses of two European ...

Roche on Tuesday said it would invest $50 billion in the United States over the next five years, a day before Swiss Finance ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

Two days after pharma companies sounded an alarm that their investments were headed out of Europe, Novartis AG has announced plans to increase investment in the U.S. by $23 billion, bringing the total ...

SAN DIEGO (FOX 5/KUSI) — Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San Diego as part of a wider effort to expand its ...

Days after President Donald Trump threatened to impose tariffs on foreign drugs, Novartis, an innovative medicines company, has announced plans to invest $23 billion over 5 years in U.S.-based ...